Today The Jennison Associates LLC Sells 142,456 Shares of Henry Schein, Inc. (HSIC)

Today The Jennison Associates LLC Sells 142,456 Shares of Henry Schein, Inc. (HSIC)

Jennison Associates LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 11.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,070,137 shares of the company’s stock after selling 142,456 shares during the period. Jennison Associates LLC’s holdings in Henry Schein were worth $174,411,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Prudential Financial Inc. raised its stake in shares of Henry Schein by 10.5% in the second quarter. Prudential Financial Inc. now owns 114,372 shares of the company’s stock valued at $20,221,000 after buying an additional 10,880 shares during the period. Ardevora Asset Management LLP raised its stake in shares of Henry Schein by 8.4% in the second quarter. Ardevora Asset Management LLP now owns 167,844 shares of the company’s stock valued at $29,675,000 after buying an additional 13,000 shares during the period. Congress Asset Management Co. MA raised its stake in shares of Henry Schein by 5.7% in the second quarter. Congress Asset Management Co. MA now owns 242,589 shares of the company’s stock valued at $42,890,000 after buying an additional 13,095 shares during the period. DE Burlo Group Inc. raised its stake in shares of Henry Schein by 7.2% in the second quarter. DE Burlo Group Inc. now owns 87,420 shares of the company’s stock valued at $15,455,000 after buying an additional 5,900 shares during the period. Finally, Reilly Herbert Faulkner III bought a new stake in shares of Henry Schein during the second quarter valued at approximately $3,482,000. Institutional investors and hedge funds own 92.33% of the company’s stock.

Henry Schein, Inc. (NASDAQ:HSIC) opened at 156.92 on Wednesday. The firm has a market capitalization of $12.63 billion, a price-to-earnings ratio of 26.06 and a beta of 1.04. The company’s 50-day moving average price is $154.51 and its 200-day moving average price is $160.57. Henry Schein, Inc. has a 12-month low of $143.64 and a 12-month high of $183.00.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.03. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.88 billion. During the same period in the prior year, the business posted $1.55 earnings per share. The business’s revenue was up 6.7% compared to the same quarter last year. Equities analysts expect that Henry Schein, Inc. will post $6.58 EPS for the current fiscal year.

A number of equities analysts have weighed in on the stock. Goldman Sachs Group, Inc. (The) raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 target price for the company in a research note on Tuesday, October 11th. Zacks Investment Research upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Wednesday, October 5th. Robert W. Baird reiterated an “outperform” rating and issued a $176.00 target price (up from $175.00) on shares of Henry Schein in a research note on Tuesday, October 4th. Gabelli upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a research note on Tuesday, January 10th. Finally, J P Morgan Chase & Co reiterated a “hold” rating and issued a $163.00 target price on shares of Henry Schein in a research note on Thursday, November 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. Henry Schein has a consensus rating of “Hold” and an average target price of $178.28.

In other news, EVP Mark E. Mlotek sold 2,417 shares of the company’s stock in a transaction on Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total transaction of $375,094.23. Following the transaction, the executive vice president now owns 40,456 shares of the company’s stock, valued at $6,278,366.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kurt P. Kuehn purchased 1,000 shares of the business’s stock in a transaction dated Monday, December 12th. The shares were purchased at an average cost of $151.41 per share, for a total transaction of $151,410.00. Following the purchase, the director now directly owns 2,039 shares of the company’s stock, valued at $308,724.99. The disclosure for this purchase can be found here. Corporate insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Related posts

Leave a Comment